Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
pages
post
Filter by Categories
All News
Case studies
News About Encare
Product updates
Publications
Upcoming events
Video & Webinars
ENHANCE ERAS® WITH ENCARE
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
pages
post
Filter by Categories
All News
Case studies
News About Encare
Product updates
Publications
Upcoming events
Video & Webinars

Webinar – Implementing ERAS® in Hip & Knee Arthroplasty

Video subtitles available. Click Settings to select your preferred language. Please note that these subtitles are auto-generated, so minor errors may occur.

In this 69-minute webinar, anaesthesiologist Dr Thomas Boogmans and pharmacist and clinical biologist Laura Bogaert from AZ Rivierenland in Belgium show how ERAS® can be successfully implemented in hip and knee arthroplasty. It is aimed at orthopaedic surgeons, anaesthesiologists, nurses, physiotherapists, quality managers and hospital leaders who are starting or improving an ERAS® pathway in orthopaedics. You will learn which care elements matter most, how AZ Rivierenland translated the ERAS® guidelines into a local protocol, and how change management turns a protocol into daily practice.

Dr Boogmans opens with the hospital's own results, monitored in the ERAS® Interactive Audit System (EIAS): a mean length of stay of 1.7 days after hip arthroplasty and 1.8 days after knee arthroplasty, and a complication rate of around 8–10% that deliberately includes postoperative pain. He then moves from Henrik Kehlet's 1997 paper to the ERAS® Society guideline for hip and knee arthroplasty published by Thomas Wainwright in 2020, with its 17 recommendations. His key message is that there is no consensus on which elements matter most, but that a core set – multimodal opioid-sparing analgesia, timely tranexamic acid and early mobilisation – appears consistently, and that higher compliance with a local protocol leads to better outcomes, as shown in the POWER2 study. He walks through the protocol at AZ Rivierenland: joint classes and an ERAS® nurse for patient education, diabetes screening, prehabilitation and nutrition, carbohydrate loading, patient blood management (up to 25% of patients are anaemic before surgery), surgery without a tourniquet, high-dose corticosteroids, intravenous tranexamic acid, mobilisation within 24 hours and nurse-led discharge criteria. Laura Bogaert then explains why ERAS® adoption varies so widely and how to lead the change: the individual change curve, adopter categories, Kotter's eight-step model, quick wins and monitoring. The session closes with the hospital's timeline from a kick-off email in 2018, via an Excel file and a free online database, to the ERAS® Implementation Program, EIAS and ERAS® Qualification in September 2023, followed by ten commandments for implementation and a Q&A on iron therapy, patient blood management, the ERAS® nurse, 90-day complications and how long to monitor a pathway.

Recorded: 4 September 2025 (live webinar)
Duration: 69 minutes
Language: English (subtitles in English, French, German, Spanish, Portuguese and Swedish)

Speakers

  • Dr Thomas Boogmans
    Anaesthesiologist and Medical Head of the Surgical Day Hospital (campus Bornem), AZ Rivierenland, Belgium – presents the ERAS® principles in hip and knee arthroplasty, the hospital's protocol and its implementation journey.
  • Laura Bogaert
    Pharmacist and Clinical Biologist, Laboratory of Clinical Biology, AZ Rivierenland, Belgium – presents the practical implementation of ERAS® and change management.
  • Charlotte Zwart
    Customer Success Manager, Encare – host and moderator.

Chapters

  • 00:00 Welcome and introduction
  • 01:32 Opening and audience poll
  • 03:01 Goals of the session
  • 03:41 Results at AZ Rivierenland
  • 05:55 What is ERAS® to you?
  • 07:12 The theory: from Kehlet to the ERAS® Society guideline
  • 10:27 What you need to know: core elements and compliance
  • 13:19 The local protocol and preoperative patient education
  • 14:57 Optimisation of chronic disease
  • 16:17 Prehabilitation, nutrition and carbohydrate loading
  • 19:33 Patient blood management
  • 21:15 Intraoperative care: surgical approach and anaesthesia
  • 23:35 Multimodal opioid-sparing analgesia
  • 25:20 Fluid therapy and high-dose corticosteroids
  • 27:16 Tranexamic acid, normothermia and PONV prophylaxis
  • 28:21 Early mobilisation and discharge criteria
  • 30:23 Thromboprophylaxis
  • 31:53 ERAS® adoption rates worldwide
  • 34:11 Change as an emotional journey and adopter categories
  • 36:41 Quality improvement and change management frameworks
  • 38:21 Kotter's eight-step change model
  • 41:08 Removing obstacles to change
  • 43:47 Quick wins, sustaining and embedding the change
  • 46:08 The implementation timeline at AZ Rivierenland
  • 48:38 Take-home messages
  • 49:21 Ten commandments for ERAS® implementation
  • 52:53 Q&A: the geriatrician in the ERAS® team
  • 54:10 Q&A: treating preoperative anaemia with iron
  • 57:16 Q&A: getting surgeons to use patient blood management
  • 1:00:08 Q&A: the role of the ERAS® nurse
  • 1:01:24 Q&A: in-hospital and 90-day complications
  • 1:02:12 Q&A: removing barriers to preoperative optimisation
  • 1:07:01 Q&A: how long to monitor an ERAS® pathway
  • 1:08:45 Closing remarks

Related resources

Want to see how EIAS can support ERAS® implementation and audit in hip and knee arthroplasty at your hospital? Book a demo

Thank you!

Your email address has been successfully submitted.

We’ll be in touch soon with more information.

Add Your Heading Text Here